<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400372</url>
  </required_header>
  <id_info>
    <org_study_id>0079-14</org_study_id>
    <nct_id>NCT02400372</nct_id>
  </id_info>
  <brief_title>The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site</brief_title>
  <official_title>The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study, &quot;Evaluation of the effect of antibacterial medical honey dressing for healing of
      implants donor area&quot;, is a Phase 4 Study, Prospective, A randomized trial, 3 arms (treatment
      groups) trial, Open-label, non-controlled, non-randomized, Aims To test the effectiveness of
      antibacterial medical honey dressing in the therapy of donor area of implants. In our
      Research Will participate in 135 new patients over the age of 18, with a wound in the donor
      area of hip implants, Hospitalized in the Plastic Surgery Unit of the &quot;Haemek&quot; Medical
      Center. Appropriate patients, who will agree to sign and sign a consent form, be assigned
      randomly to one of three treatment groups:

        1. The research group: Medihoney antibacterial wound dressing.

        2. The control group: Paraffin gauze with saline- The basic treatment in the donor site,
           accepted the literature.

        3. Comparison group: Polymem dressing - Common treatment in the donor site in the Plastic
           Surgery Unit of the &quot;Haemek&quot; Medical Center.

      Participants in the three study groups will be performed, each visit, Medical monitoring and
      examination by a team of medical indices of Plastic Surgery Unit, as is customary. The
      treatment will be performed, twice a week until recovery and the complete closure of the
      wound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study protocol The aim of this study is to evaluate &quot;The effect of anti-bacterial honey
      dressing on the healing of split thickness skin graft donor site&quot;.

      Protocol Abstract. The use of skin grafts for wound closure is considered one of the common
      methods in the field of plastic surgery. Healing of the donor area is secondary, gradual and
      is a serious problem, Associated with a high percentage of wound infections, Delay in
      healing, Scars, Pain unpleasant odor and other problems. As of today, there is no ideal
      treatment to cure the donor area of implants, due to lack of high-quality comparative
      studies. The use of honey to treat wounds known for centuries in different cultures. Honey
      has anti-inflammatory and anti-bacterial effect, Debridement ability, and Pain relief. Honey
      has almost no side effects. Effectiveness of honey in wound healing has been tested in many
      clinical trials, but most of them and some methodological problems of low quality. Therefore,
      it is difficult to conclude that the existing information handling guidelines and
      recommending further clinical research.

      The study, &quot;Evaluation of the effect of antibacterial medical honey dressing for healing of
      implants donor area&quot;, is a Phase 4 Study, Prospective, A randomized trial, 3 arms (treatment
      groups) trial, Open-label, non-controlled, non-randomized, Aims To test the effectiveness of
      antibacterial medical honey dressing in the therapy of donor area of implants. In our
      Research Will participate in 135 new patients over the age of 18, with a wound in the donor
      area of hip implants, Hospitalized in the Plastic Surgery Unit of the &quot;Haemek&quot; Medical
      Center. Appropriate patients, who will agree to sign and sign a consent form, be assigned
      randomly to one of three treatment groups:

        1. The research group: Medihoney antibacterial wound dressing.

        2. The control group: Paraffin gauze with saline- The basic treatment in the donor site,
           accepted the literature.

        3. Comparison group: Polymem dressing - Common treatment in the donor site in the Plastic
           Surgery Unit of the &quot;Haemek&quot; Medical Center.

      Participants in the three study groups will be performed, each visit, Medical monitoring and
      examination by a team of medical indices of Plastic Surgery Unit, as is customary. The
      treatment will be performed, twice a week until recovery and the complete closure of the
      wound.

      Research Goals Primary goal Examining the effect of Medihoney antibacterial wound dressing
      honey on the duration of the donor site area healing, until full recovery and wound closure.

      Secondary objectives

        1. To Evaluatee the effect of Medihoney antibacterial wound dressing on pain intensity
           donor site.

        2. . To Evaluatee the effect of Medihoney antibacterial wound dressing on the frequency of
           infections in donor site.

      Tertiary goal

        1. To evaluate the effect of Medihoney antibacterial wound dressing on the unpleasant odor
           in the donor site.

        2. 2. To evaluate the effect of Medihoney antibacterial wound dressing on patient
           satisfaction from treatment in donor site.

      Research Hypothesis Medihoney antibacterial wound dressing will find significantly
      statistical more effective in comparison with Paraffin gauze with saline dressing and
      compared with Polymem dressing, In terms of duration of a treatment, Intensity of pain and
      the prevalence of infection in the donor site.

      Treatment regimen First group Immediately after harvesting the skin, the donor site will be
      covered with a thin layer of Medihoney Antibacterial Wound Gel and Xtrasorb Super Absorbent
      Dressing will used as secondary dressing. After 24 hours, the dressing will be replaced by
      Medihoney HCS dressing.

      Medihoney HCS dressing will be replace twice a week.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Examining the effect of Medihoney antibacterial wound dressing honey on the duration of the donor site area healing, until full recovery and wound closure</measure>
    <time_frame>25 days</time_frame>
    <description>The Outcome will be assessed by Medical examination and Laboratory Testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To Evaluatee the effect of Medihoney antibacterial wound dressing on the frequency of infections in donor site.</measure>
    <time_frame>25 days</time_frame>
    <description>The Outcome will be assessed by Medical examination and Laboratory Testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To Evaluatee the effect of Medihoney antibacterial wound dressing on pain intensity donor site.</measure>
    <time_frame>25 days</time_frame>
    <description>The Outcome will be assessed by Medical examination and Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the effect of Medihoney antibacterial wound dressing on the unpleasant odor in the donor site.</measure>
    <time_frame>25 days</time_frame>
    <description>The Outcome will be assessed by Medical examination and Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the effect of Medihoney antibacterial wound dressing on patient satisfaction from treatment in donor site.</measure>
    <time_frame>25 days</time_frame>
    <description>The Outcome will be assessed by Medical examination and Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Disorder of Skin Donor Site</condition>
  <arm_group>
    <arm_group_label>research group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medihoney Dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Paraffin gauze with saline Dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. Comparison group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Polymem dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>medihoney dressing</intervention_name>
    <description>to evaluate the effect of medihoney dressing on the healing of split thickness skin graft donor site</description>
    <arm_group_label>research group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a wound on the hip - the implant donor area

          -  Wound size up to 100 smÂ²

        Exclusion Criteria:

          -  Known sensitivity of the patient to honey

          -  Pregnant women

          -  Patients under 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aziz Shufani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek Medical Center, Afula</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>gilat Ron avraham</last_name>
    <phone>972-52-8495336</phone>
    <email>gilat_av@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>HaEmekMC</name>
      <address>
        <city>`Afula</city>
        <zip>18341111</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2015</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

